home
docs

Liberia Access to anti-retroviral drugs, female (%) 2026: Interactive Chart & Historical Data

Access to anti-retroviral drugs, female (%) in Liberia stood at 96% in 2024, according to World Bank. The latest value is up 15 percentage points from 81% in 2023. Ten years earlier, in 2014, the value was 22% (up 74 percentage points since). The latest value is the highest since 2000; the lowest was 0% in 2000. Liberia ranked 14th highest of the 123 countries in this dataset in 2024; Azerbaijan ranked first.

Data source: World Bank · Unit: % · Category: Demographics · Explore more indicators on EconDash

Data updated:Last checked:Frequency:AnnualCoverage:2000–2024

Key facts

What is the latest Access to anti-retroviral drugs, female (%) in Liberia?

Access to anti-retroviral drugs, female (%) in Liberia stood at 96% in 2024, according to World Bank.

Is Access to anti-retroviral drugs, female (%) in Liberia rising or falling?

The latest value is up 15 percentage points from 81% in 2023. Ten years earlier, in 2014, the value was 22% (up 74 percentage points since).

How does Liberia rank for Access to anti-retroviral drugs, female (%)?

Liberia ranked 14th highest of the 123 countries in this dataset in 2024; Azerbaijan ranked first.

What is the highest Access to anti-retroviral drugs, female (%) on record in Liberia?

The latest value is the highest since 2000; the lowest was 0% in 2000.

Metadata for Access to anti-retroviral drugs, female (%) in Liberia
IndicatorAccess to anti-retroviral drugs, female (%)
CountryLiberia
CategoryDemographics
Unit%
SourceWorld Bank
Interactive chartView on EconDash
API accessEconDash API documentation

Latest value: 96% (2024)

Loading chart...

Source:World Bank — series SH.HIV.ARTC.FE.ZS
License:CC BY 4.0
Cite this chart
APA

World Bank. (2026). Access to anti-retroviral drugs, female (%) — Liberia [Data set]. Retrieved November 13, 2026, from EconDash: https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/LBR. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS

MLA

World Bank. "Access to anti-retroviral drugs, female (%) — Liberia." EconDash, 2026, https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/LBR. Accessed 13 Nov. 2026. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS.

Chicago

World Bank. 2026. "Access to anti-retroviral drugs, female (%) — Liberia." EconDash. Accessed November 13, 2026. https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/LBR. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS.

BibTeX
@misc{econdash_wdi_sh_hiv_artc_fe_zs_lbr,
  author = {{World Bank}},
  title = {{Access to anti-retroviral drugs, female (\%) --- Liberia}},
  howpublished = {EconDash},
  year = {2026},
  url = {https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/LBR},
  note = {Accessed: 2026-11-13. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS}
}